Symbiosis Pharmaceutical Services Ltd. is a UK-based Contract Development and Manufacturing Organisation (CDMO) specialising in GMP sterile manufacture of biopharmaceuticals for clinical trial and commercial supply globally.

Operating from FDA-inspected and MHRA-licensed facilities, Symbiosis provides an integrated parenteral manufacturing service, from formulation through to aseptic fill-finish of liquid and lyophilised therapeutics, as well as analytical testing, inspection, packaging and labelling, Qualified Person (QP) release, and temperature-controlled storage and shipment.

The company focuses on collaborative partnerships, offering operational flexibility, technical expertise, and regulatory compliance to support the timely delivery of safe injectable therapies.

For more information, please visit www.symbiosis-pharma.com

Key Products and Services:

Sterile Fill-Finish / Aseptic Filling: Sterile filling of liquid and lyophilised products for both clinical and commercial supply.
Bulk Lyophilization: Integration of lyophilization or gas overlay into liquid fill processes as part of aseptic manufacturing.
Drug Product Testing: Coordination of analytical and microbiological testing requirements.
Qualified Person (QP) Release: GMP confirmation and certification by a Qualified Person to support product release to clinical trials, commercial markets, or for onward processing.
Clinical Labelling and Packaging: Dedicated suites and automation capabilities for labelling and packaging of clinical and commercial batches.
Product Development: End-to-end manufacturing process development, including formulation, lyophilization cycle development, filter compatibility assessment, and container closure studies.
Complex Modalities Expertise: Experience in handling a range of complex therapeutic modalities.